تخطَّ إلى المحتوى
دليل الأدوية المصري
تابع آخر تحديثات الأسعار على واتساب

دواعي استعمال تايجاسيل 50مجم فيال وريد

معلومات من نشرات دوائية ومراجع موثقة، مع مصدر كل معلومة. السعر الحالي: —.

عن الدواء

Tygacil (tigecycline) 50 mg lyophilised powder for intravenous infusion, single vial, Pfizer.

دواعي الاستعمال
  • Complicated skin and skin structure infectionsالفئة: Patients 18 years and olderDailyMed (U.S. National Library of Medicine)
  • Complicated intra-abdominal infectionsالفئة: Patients 18 years and olderDailyMed (U.S. National Library of Medicine)
  • Community-acquired bacterial pneumoniaالفئة: Patients 18 years and olderDailyMed (U.S. National Library of Medicine)
الآثار الجانبية
  • Most common: nausea and vomiting, diarrhoea, infection, increased ALT/AST, abdominal pain.نشرة دولية لنفس المنتج · DailyMed (U.S. National Library of Medicine)
موانع الاستعمال
  • Known hypersensitivity to tigecycline.نشرة دولية لنفس المنتج · DailyMed (U.S. National Library of Medicine)
تحذيرات واحتياطات
  • BOXED WARNING - all-cause mortality: increased all-cause mortality vs comparators in clinical trials; reserve for situations where alternative treatments are not suitable. Also: anaphylaxis, hepatotoxicity, pancreatitis, hypofibrinogenaemia/coagulopathy (monitor fibrinogen), tooth discoloration and enamel hypoplasia if used during tooth development (pregnancy, children <8 years), C. difficile-associated diarrhoea.نشرة دولية لنفس المنتج · DailyMed (U.S. National Library of Medicine)
التداخلات الدوائية
  • WarfarinMonitor prothrombin time/INR when co-administered.DailyMed (U.S. National Library of Medicine)
  • Calcineurin inhibitors (tacrolimus, cyclosporine)May increase their trough concentrations; monitor levels.DailyMed (U.S. National Library of Medicine)
  • Oral contraceptivesConcurrent antibacterial use may render oral contraceptives less effective.DailyMed (U.S. National Library of Medicine)
الحمل والرضاعة
  • May cause fetal harm; use during the second and third trimesters can cause permanent tooth discoloration and reversible inhibition of bone growth in the fetus.نشرة دولية لنفس المنتج · DailyMed (U.S. National Library of Medicine)
  • No data on tigecycline in human milk (tetracycline-class drugs are present in breast milk); low oral bioavailability so infant exposure expected to be low; weigh benefits of breastfeeding against the mother's need for the drug.نشرة دولية لنفس المنتج · DailyMed (U.S. National Library of Medicine)

المصادر